American Association for Cancer Research

Press Releases: 2010

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page 

Susan Band Horwitz, Ph.D., Receives AACR Award for Lifetime Achievement in Cancer Research

February 10, 2011

ORLANDO, Fla. — Susan Band Horwitz, Ph.D., will receive the Eighth AACR Award for Lifetime Achievement in Cancer Research. Horwitz conducted...

Stand Up To Cancer Acquires TV & Film Rights to Nonfiction Bestseller "Emperor of All Maladies"

December 15, 2010

Stand Up To Cancer (SU2C), the charitable initiative generating public awareness of and support for ground-breaking research aimed at getting new...

Immune System May Impact Tumor Blood Supply

December 15, 2010

PHILADELPHIA — Scientists at the Dana-Farber Cancer Institute may have uncovered a mechanism for blocking tumor angiogenesis that involves the...

Higher Co-payments Increase Chance of Early Discontinuation, Inadequate Use of Breast Cancer Therapy

December 11, 2010

SAN ANTONIO — A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use...

Unique Needs and Outcomes of Pregnant Women with Breast Cancer Identified

December 11, 2010

SAN ANTONIO — Do not delay treatment of breast cancer just because a woman is pregnant, said lead researcher Sibylle Loibl, Dr. med, of the...

Phase III Efficacy Data on Bevacizumab Plus Chemotherapy in Early Breast Cancer to be Presented

December 10, 2010

SAN ANTONIO — Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women...

CTCs Predict Poor Outcome From Blood Stem Cell Transplantation Therapy for Metastatic Breast Cancer

December 10, 2010

SAN ANTONIO — Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy...

Denosumab Delayed Time to First Skeletal-related Side Effect

December 10, 2010

SAN ANTONIO — For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared...

High CTC Levels Predicted Poor Outcome in Metastatic Breast Cancer

December 10, 2010

SAN ANTONIO — A high level of circulating tumor cells (CTCs) — cells that have detached from a tumor and are circulating in the body...

Circulating Tumor Cells Predicted Recurrence, Death in Patients with Early-stage Breast Cancer

December 10, 2010

SAN ANTONIO — The presence of one to four circulating tumor cells (CTCs) in the blood of early-stage breast cancer patients almost doubled...

Pertuzumab and Trastuzumab Combination Improved Efficacy for Women With HER2-positive Breast Cancer

December 10, 2010

SAN ANTONIO — The combination of pertuzumab and trastuzumab had superior antitumor activity in women with early HER2-positive breast cancer,...

Combination Therapy Reduced HER2-positive Breast Cancers

December 10, 2010

SAN ANTONIO — A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among...

Phase III Study Compared Neoadjuvant Therapy with Lapatinib or Trastuzumab for Early Breast Cancer

December 10, 2010

SAN ANTONIO — Researchers presented Phase III efficacy data from the GeparQuinto study, a head-to-head comparison of neoadjuvant lapatinib and...

New Surgeon General Report on Smoking and Disease Caps Successful Year of Federal Anti-Tobacco Action, AACR Says

December 9, 2010

WASHINGTON, D.C. — The American Association for Cancer Research commends the U.S. Office of the Surgeon General for its continued focus on...

Zoledronic Acid Did Not Improve Disease-Free Survival in Early Breast Cancer

December 9, 2010

SAN ANTONIO — Zoledronic acid did not improve disease free survival among women with stage II/III breast cancer according to results of the...

Exemestane may be Another First-line, Adjuvant Therapy for Hormone-receptor Positive, Early-stage Breast Cancer

December 9, 2010

SAN ANTONIO — Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal...

Obese Women with ER-positive/HER2-negative Breast Cancer Have Poorer Survival Rates

December 9, 2010

SAN ANTONIO — Obesity was associated with worse overall and disease-free survival in women with operable breast cancer treated with adjuvant...

Most Women Do Not Get Recommended Mammograms

December 9, 2010

SAN ANTONIO — Only half of eligible women in the United States are getting their annual mammograms, even if they have insurance to pay for the...

Estrogen Alone is Effective for Reducing Breast Cancer Risk

December 9, 2010

SAN ANTONIO — While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact,...

Aromatase Inhibitors Increased Risk of Heart Disease in Postmenopausal Women with Breast Cancer

December 9, 2010

SAN ANTONIO — Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing...

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page